2022 annual financial data
Wave Life Sciences 2022 Operating margin
Wave Life Sciences 2022 operating margin with verified reported values.
Direct answer
Operating margin was -4,459.3%.
Operating income was -162,720,000 USD and net income was -161,823,000 USD.
Operating cash flow was -127,781,000 USD.
Get free Wave Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,649,000 USD
- Operating income
- -162,720,000 USD
- Net income
- -161,823,000 USD
- Operating cash flow
- -127,781,000 USD